SFI
TTOO

Susquehanna Fundamental Investments’s T2 Biosystems, Inc TTOO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19
Closed -$157K – 1814
2021
Q1 		$157K Buy
+19
New +$201K ﹤0.01% 1420
2020
Q4 		– Sell
-11
Closed -$72K – 1641
2020
Q3 		$72K Buy
+11
New +$81.5K ﹤0.01% 1309

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna Fundamental Investments's TTOO Position: Q2 2021 in Review

Susquehanna Fundamental Investments sold out of T2 Biosystems, Inc (TTOO) in Q2 2021, closing a stake of 19 shares — an estimated $157K sold.

Susquehanna Fundamental Investments first reported a position in TTOO in Q3 2020 and held it in 2 quarters. The position peaked at $157K in Q1 2021. 78 funds tracked by Wall St. Rank hold TTOO as of Q2 2021.

  • Susquehanna Fundamental Investments reported no remaining T2 Biosystems, Inc position as of Q2 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 19 T2 Biosystems, Inc shares in Q2 2021, an estimated $157K.
  • Susquehanna Fundamental Investments first reported a position in T2 Biosystems, Inc in Q3 2020 and held it in 2 quarters.
  • Susquehanna Fundamental Investments's T2 Biosystems, Inc position peaked at $157K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2021, filed 11 Aug 2021.